Unigestion to absorb research costs ahead of Mifid II

Unigestion to absorb research costs ahead of Mifid II

Swiss manager Unigestion has followed the path traced out by Vanguard, JP Morgan and other asset management firms by announcing it will pay for all investment research on behalf of its clients in line with the forthcoming implementation of Mifid II at the start of 2018.

Mifid II is letting the choice to asset managers for the payment of investment research: paying for it or charging clients through a research payment account.

Unigestion therefore has chosen to pay for all investment research from its own profit and loss.

The company said this approach is consistent with the its core value of always putting its clients first. It highlighted that costs and charges delivery of its products across all asset classes will be fully transparent.

This decision will not result in any change in management fees, Unigestion added.

Fiona Frick (pictured), CEO of Unigestion, said: “Our clients are at the heart of everything that we do and the reasons behind our decision to pay for all research ourselves go beyond regulation. It is quite simply the right thing to do to ensure that we continue to give our clients the clearest picture of how and why they are being charged for our products, alongside safeguarding them from any potential conflicts of interest in providing best execution.

“Both our bespoke in-house research and the research provided through external providers are integral to our investment process. We will continue to use them both in tandem to deliver the best possible investment solutions and returns to our clients globally.”

More on